Telemetry Investments, L.L.C. Verastem, Inc. Call Options Transaction History

Telemetry Investments, L.L.C.

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q1 2019 May 15, 2019	SELL	$2.79 - $4.09 $139,500 - $204,500	-50,000 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$3.23 - $7.01 $161,500 - $350,500	50,000 New	50,000 $168,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $790M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Telemetry Investments, L.L.C. with notifications on news.